Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565957 | 0.93 | LMNA (0.69) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL5710874 | 0.87 | ALDH1A1 (0.65) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL1282917 | 0.87 | ALDH1A1 (0.65) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL24729065 | 0.86 | ALDH1A1 (0.63) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL5710869 | 0.86 | ALDH1A1 (0.63) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL6565963 | 0.85 | ESR1 (0.69) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL8356074 | 0.85 | TDP1 (0.79) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL2875064 | 0.84 | KDM4E (0.62) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL9574717 | 0.84 | HTT (0.73) | KMT2ATDP1SLC6A3SLC6A2ALDH1A1 | |
| SCHEMBL5706020 | 0.83 | SLC6A3 (0.69) | KMT2ASLC6A3ALDH1A1CYP2C9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-215728923-U | Light guide plate with good light guide effect | 江门市中塑板材有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-114410096-B | Cobalt-containing organic montmorillonite modified heat aging resistant flame retardant PC optical film material and preparation method thereof | 西南科技大学 | 2023-09-22 | — | — | CN | disclosed |
| CN-114410096-A | Co-containing organic montmorillonite modified heat-aging-resistant flame-retardant PC optical film material and preparation method thereof | 西南科技大学 | 2022-04-29 | — | — | CN | disclosed |
| CN-215728923-U | Light guide plate with good light guide effect | 江门市中塑板材有限公司 | 2022-02-01 | — | — | CN | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008070368-A2 | METHODS AND COMPOSITIONS FOR SKIN CARE | LIVING PROOF, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| US-20050244441-A1 | Cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | KMT2A 2537/4885TDP1 298/4885SLC6A3 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.